Prostate Cancer: Man’s Plea for Screening After Late Diagnosis | UK News
The debate surrounding prostate cancer screening continues to intensify, with growing calls for a more targeted approach despite recent recommendations against population-level screening from the UK’s National Screening Committee. This discussion is deeply personal for many, including former Prime Minister David Cameron, who recently revealed his prostate cancer diagnosis and is now advocating for increased screening options.
Cameron, 59, discovered his cancer after a prostate-specific antigen (PSA) test revealed a high result, followed by a biopsy. He described the experience as deeply unsettling, recalling the moment he received the diagnosis: “You always dread hearing those words. And then literally as they’re coming out of the doctor’s mouth you’re thinking, ‘Oh, no, he’s going to say it. He’s going to say it. Oh God, he said it.’” He received focal therapy, a treatment that uses electrical pulses to target and destroy cancer cells.
His experience underscores the emotional toll of a cancer diagnosis, particularly when it’s considered incurable. Tony Collier, diagnosed with incurable prostate cancer in , shared a similar sentiment. Being told you have cancer is devastating; being told it’s incurable is indescribable and you immediately go to a very dark place,
he said. Collier believes that earlier detection through a simple blood test could have dramatically altered his prognosis. He was diagnosed only after seeking medical attention for a groin strain sustained while training for a marathon.
Collier’s initial reaction to the diagnosis was one of despair, focusing on the projected timeline of two to three years
to live. He recounts spending 18 months after my diagnosis thinking so much of dying that I forgot the joy of living.
He ultimately realized the importance of shifting his focus to living fully in the present.
This sentiment was echoed by his wife, Tracey, who urged him to make the most of his time. I did say to him at the time ‘If you’re still here then you’ve wasted 12 months.’
Don’t waste a day, don’t just sit in a chair and wait for it to end.
she told him.
The urgency felt by individuals like Collier fuels the push for a national screening program. He is now determined to prevent others from facing a similar late-stage diagnosis. It’s really important that we save as many men’s lives as possible. And 12,000 men are dying every year. That’s one every 45 minutes,
Collier stated. The quicker we stop that, the better. And the only way we can stop that is with a screening programme.
Prostate cancer is a complex disease and the debate over screening reflects the inherent challenges in balancing the potential benefits of early detection against the risks of overdiagnosis, and overtreatment. A PSA test measures the level of prostate-specific antigen in the blood. Elevated levels can indicate prostate cancer, but can also be caused by other, less serious conditions, such as benign prostatic hyperplasia (BPH) or prostatitis. This can lead to unnecessary biopsies, which carry their own risks, including infection, bleeding, and anxiety.
The UK National Screening Committee’s recent recommendation against population-level screening suggests that, at present, the harms may outweigh the benefits for the general male population. However, the call for targeted
screening, as advocated by Cameron and others, proposes a more nuanced approach. This would involve identifying men at higher risk of developing aggressive prostate cancer – potentially through factors like family history, ethnicity, or genetic predisposition – and offering them screening more proactively.
The screening committee is expected to finalize its recommendations to the governments of the four UK nations later this month, following the conclusion of a consultation process in . The outcome of this deliberation will likely have a significant impact on the future of prostate cancer detection and treatment in the UK.
While awaiting formal policy changes, raising awareness remains crucial. As Collier emphasizes, In the meantime, we’ve just got awareness. That’s all we’ve got left.
Early recognition of symptoms, open communication with healthcare providers, and informed decision-making are vital steps men can take to protect their health.
It’s important to remember that prostate cancer often develops slowly, and many men diagnosed with the disease will never experience symptoms or require treatment. However, for those who do, early detection can significantly improve outcomes. The ongoing discussion highlights the need for continued research, improved risk assessment tools, and a patient-centered approach to prostate cancer screening and care.